May 17, 2013
Yakult Honsha, at an earnings conference on May 13 in Tokyo, said that it will file for additional indications of pancreas cancer this month and relapsed, advanced gastric cancer in July for its major product Elplat (oxaliplatin), an anticancer agent...read more